Piper Sandler on Tenaya Therapeutics Inc (TNYA): 'TN-301 Can Become a Key Value Driver for TNYA'
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $40.00 price target on Tenaya Therapeutics Inc (NASDAQ: TNYA).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
